The Effective Use of Digoxin in a Patient with Metastatic Breast Cancer and Anthracycline-induced Cardiomyopathy.

Author: ArakawaYasuhiro, ImJihaeng, KikuchiNoriko, ShigaTsuyoshi

Paper Details 
Original Abstract of the Article :
Anthracyclines have cardiotoxic side effects. Cardioprotective drugs such as angiotensin-converting enzyme inhibitors and beta-blockers are therefore recommended for patients with anthracycline-induced cardiomyopathy. We herein present a 54-year-old woman with recurrent metastatic breast cancer who ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479229/

データ提供:米国国立医学図書館(NLM)

Digoxin's Role in Treating Anthracycline-Induced Cardiomyopathy

In the realm of cancer treatment, anthracyclines are a powerful weapon, but like a double-edged sword, they can cause unintended damage to the heart, leading to a condition known as cardiomyopathy. This research delves into the use of digoxin, a medication typically associated with heart rhythm problems, as a potential treatment for this serious side effect of cancer therapy. The study presents a case of a 54-year-old woman with metastatic breast cancer who developed heart failure after undergoing chemotherapy. Her heart condition, a desert of weakened heart muscle, persisted despite standard treatments. However, a surprising oasis emerged when digoxin was introduced, leading to a significant improvement in her heart function.

A New Hope for Heart Failure

This research, like a camel finding water in the desert, offers hope for patients with anthracycline-induced cardiomyopathy. Digoxin, typically used for heart rhythm issues, showed remarkable effectiveness in improving heart function in a patient resistant to traditional treatments. This finding opens doors to new treatment possibilities for a condition that can significantly impact a patient's quality of life.

Listen to Your Heart

This research underscores the importance of carefully monitoring patients receiving anthracyclines for potential heart damage. While these drugs can be lifesavers, it's crucial to be aware of their potential side effects. If you're undergoing cancer treatment with anthracyclines, it's essential to discuss your heart health with your doctor. They can help you understand the risks and benefits of this therapy and develop a personalized treatment plan that considers both your cancer and your heart health.

Dr. Camel's Conclusion

This research highlights the versatility of digoxin, demonstrating its potential to address a challenging complication of cancer treatment. By exploring alternative treatment options, we may find new ways to navigate the treacherous terrain of heart failure, providing hope for those affected by this debilitating condition.
Date :
  1. Date Completed 2021-09-03
  2. Date Revised 2021-10-09
Further Info :

Pubmed ID

33746165

DOI: Digital Object Identifier

PMC8479229

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.